Yaoyu Yang
Founder & CEO

Cypher AI provides an AI‑powered platform that automates the analysis of large genomic and proteomic datasets. By applying deep‑learning models, it predicts variant effects, profiles gene expression, and prioritizes therapeutic targets, delivering annotated results, confidence scores, and visualizations through a secure web interface and API integration for pharma, biotech, and academic researchers.
Founder & CEO
Founder
Founder
Founder
Founder
Biological research generates massive genomic and proteomic datasets that are difficult to analyze quickly and accurately, limiting the ability of scientists to derive actionable insights for drug discovery and personalized medicine.
Cypher AI offers an artificial intelligence platform that automates the interpretation of large-scale biological data. The system applies deep learning models to identify patterns, predict functional effects of genetic variants, and prioritize therapeutic targets. Users upload raw sequencing or expression data, and the platform returns annotated results, confidence scores, and visualizations through a secure web interface. Integration with existing bioinformatics pipelines is supported via APIs, enabling researchers to incorporate AI-driven analysis without redesigning their workflows. Continuous model updates incorporate the latest scientific literature and public datasets, improving prediction accuracy over time.
Primary customers are pharmaceutical R&D teams, biotech companies, and academic research labs that need rapid, AI‑enhanced analysis of genomic and proteomic data.